
NVIDIA Expands BioNeMo Platform to Accelerate AI-Driven Drug Discovery
February 9, 2026
NVIDIA has expanded its BioNeMo platform with new models, tools, and partnerships, enabling autonomous, AI-driven biology and drug discovery while reducing R&D costs and speeding up scientific breakthroughs.